
Sign up to save your podcasts
Or


Credits: 0.50 AMA PRA Category 1 Credits™, 0.50 ABIM MOC or 0.52 AANP including 0.52 AANP Pharm
Overview: Explore the evolving role of post-exposure prophylaxis (PEP) for COVID-19 in high-risk populations. Join infectious disease experts from Johns Hopkins as they discuss the latest data, clinical considerations, and promising agents in reducing severe outcomes when vaccination alone may not be enough.
By Pri-Med4.5
8585 ratings
Credits: 0.50 AMA PRA Category 1 Credits™, 0.50 ABIM MOC or 0.52 AANP including 0.52 AANP Pharm
Overview: Explore the evolving role of post-exposure prophylaxis (PEP) for COVID-19 in high-risk populations. Join infectious disease experts from Johns Hopkins as they discuss the latest data, clinical considerations, and promising agents in reducing severe outcomes when vaccination alone may not be enough.

136 Listeners

700 Listeners

497 Listeners

255 Listeners

295 Listeners

259 Listeners

3,337 Listeners

1,151 Listeners

194 Listeners

92 Listeners

512 Listeners

366 Listeners

247 Listeners

372 Listeners

314 Listeners